Skip to main content
. 2022 Oct 29;11(11):1511. doi: 10.3390/antibiotics11111511

Table 6.

Univariate and multivariate analysis of the economic impact (total costs in euros) per hospital admission according to different variables.

Variables Univariate
MD (95% CI)
p-Value Multivariate
MD (95% CI)
p-Value
XDR P. aeruginosa 3612.06 (−2204.66, 9428.78) 0.222 3003.16 (−2216.81, 8223.13) 0.258
Bacteremia 16744.23 (10159.42, 23329.04) <0.001 16228.95 (10394.83, 22063.06) <0.001
Nosocomial acquisition 15521.47 (9229.19, 21813.75) <0.001 13401.76 (8228.21, 18575.31) <0.001
Appropriate empirical treatment 5023.74 (−994.78, 11042.26) 0.101
Charlson comorbidity index 276.42 (−944.95, 1497.79) 0.656 100.64 (−912.31, 1113.60) 0.845
Age −107.81 (−335.44, 119.83) 0.351 21.48 (−196.27, 239.24) 0.846
SOFA 881.76 (−153.23, 1916.75) 0.094 613.66 (−313.33, 1540.66) 0.193
Length of hospital stay (days) from onset of UTI 602.95 (544.58, 661.32) <0.001

Abbreviations: MD (Median Difference), XDR (Extensively drug-resistant), SOFA (Sequential Organ Failure Assessment), UTI (urinary tract infection).